The Journal of allergy and clinical immunology · 1986
Immunoregulatory disorders associated with hereditary angioedema. II. Serologic and cellular abnormalities.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Brickman C M, Tsokos G C, Chused T M, Balow J E, Lawley T J, Santaella M, Hammer C H, Linton G F, Frank M M
Аннотация
Hereditary angioedema is defined biochemically by a deficiency in the functional activity of the inhibitor of Cl, Cl esterase inhibitor (Cl INH). Deficiency of this regulator of the early classic pathway of complement results in chronic activation of this cascade with a resultant deficiency of C4 and C2. Ninety-seven patients with either complicated (associated with autoimmune disorders) or uncomplicated hereditary angioedema were evaluated for laboratory evidence of immunoregulatory defects. Specific cellular and humoral abnormalities were found and included increased mean total lymphocyte counts, increased mean Leu 4+ (total) and Leu 3+ (helper) T cells, an increased mean Leu 3/Leu 2 (helper/suppressor T cell) ratio, polyclonal B cell activation, and evidence of circulating immune complexes. C4 functional titers were negatively correlated with percent Leu 3+ cells and absolute Leu 3+ cell numbers. We failed to detect any evidence of immune deficiency in this population, and yet a statistically significant number of patients demonstrated elevated levels of antibodies to Epstein-Barr virus antigens when patients were compared to a control group. Thus, early classic complement pathway activation and/or partial complement component deficiency may effect T cell subpopulations and B cell activation. However, additional predisposing factors (e.g., genetic or viral) appear necessary for the development of a particular autoimmune disease in hypocomplementemic patients.
Предметные рубрики MeSH
AdolescentAdultAgedAngioedemaAntigen-Antibody ComplexAutoimmune DiseasesB-LymphocytesC-Reactive ProteinChildComplement ActivationComplement C4FemaleHLA-DR AntigensHaploidyHistocompatibility Antigens Class IIHumansImmune SystemImmunity, CellularImmunoglobulin AImmunoglobulin GImmunoglobulin MInterleukin-1Interleukin-2Leukocyte CountLymphocyte ActivationLymphocytesMaleMiddle AgedT-Lymphocytes